Assessing self-reported use of new psychoactive substances: The impact of gate questions

Underreporting of ecstasy use among high school seniors in the US

(2016) Joseph J. Palamar et al.   DRUG AND ALCOHOL DEPENDENCE

Detection of “bath salts” and other novel psychoactive substances in hair samples of ecstasy/MDMA/“Molly” users

(2016) Joseph J. Palamar et al.   DRUG AND ALCOHOL DEPENDENCE

New psychoactive substance use among regular psychostimulant users in Australia, 2010–2015

(2016) Rachel Sutherland et al.   DRUG AND ALCOHOL DEPENDENCE

Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project

(2016) Tibor M. Brunt et al.   Drug Testing and Analysis

Crystals and tablets in the Spanish ecstasy market 2000–2014: Are they the same or different in terms of purity and adulteration?

(2016) Claudio Vidal Giné et al.   FORENSIC SCIENCE INTERNATIONAL

Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class

(2016) Julia Dinger et al.   TOXICOLOGY LETTERS

Discordant reporting of nonmedical opioid use in a nationally representative sample of US high school seniors

(2016) Joseph J. Palamar et al.   AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE

Self-reported use of novel psychoactive substances among attendees of electronic dance music venues

(2016) Joseph J. Palamar et al.   AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE

Synthetic cannabinoid use in a nationally representative sample of US high school seniors

(2015) Joseph J. Palamar et al.   DRUG AND ALCOHOL DEPENDENCE

Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting

(2015) Joseph J. Palamar et al.   DRUG AND ALCOHOL DEPENDENCE

Monitoring new psychoactive substances (NPS) in The Netherlands: Data from the drug market and the Poisons Information Centre

(2015) Laura Hondebrink et al.   DRUG AND ALCOHOL DEPENDENCE

Characteristics of novel psychoactive substance exposures reported to New York City Poison Center, 2011–2014

(2015) Joseph J. Palamar et al.   AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE

The rise of new psychoactive substance use in Australia

(2014) Lucy Burns et al.   Drug Testing and Analysis

New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon?

(2014) Claudio Vidal Giné et al.   Drug Testing and Analysis

Presence and composition of cathinone derivatives in drug samples taken from a Drug Test Service in Spain (2010-2012)

(2013) Fernando Caudevilla-Gálligo et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

What are we missing? The costs versus benefits of skip rule designs

(2013) Sonja A. Swanson et al.   INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH

Dimethyltryptamine (DMT): Prevalence, user characteristics and abuse liability in a large global sample

(2013) Adam R Winstock et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Emerging psychoactive substance use among regular ecstasy users in Australia

(2011) Raimondo Bruno et al.   DRUG AND ALCOHOL DEPENDENCE